Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥6.22B | ¥5.80B | ¥5.47B | ¥3.27B | ¥1.78B | ¥1.30B | ¥2.23B | ¥2.88B | ¥2.25B |
| Research & development | ¥427.1M | ¥372.4M | ¥296.3M | ¥216.7M | ¥143.7M | ¥151.6M | ¥201.4M | ¥184.3M | ¥181.0M |
| Operating income | ¥1.80B | ¥1.25B | ¥1.33B | ¥1.18B | ¥432.0M | ¥302.1M | ¥534.7M | ¥685.2M | ¥686.7M |
| EBITDAderived | ¥1.87B | ¥1.27B | ¥1.34B | ¥1.19B | ¥447.6M | ¥325.3M | ¥552.4M | ¥696.5M | ¥690.8M |
| Net income | ¥1.54B | ¥1.06B | ¥1.30B | ¥1.18B | ¥472.1M | ¥252.9M | ¥527.7M | ¥611.8M | ¥539.5M |
| Basic EPSper diluted share | CN¥7.35 | CN¥4.97 | CN¥6.06 | CN¥5.48 | CN¥2.18 | CN¥1.17 | CN¥2.51 | CN¥3.06 | CN¥2.70 |
| Diluted EPSper diluted share | CN¥7.35 | CN¥4.97 | CN¥6.06 | CN¥5.48 | CN¥2.18 | CN¥1.17 | CN¥2.51 | CN¥3.06 | CN¥2.70 |